GB917012A - Reagent for the control of coagulability of blood - Google Patents

Reagent for the control of coagulability of blood

Info

Publication number
GB917012A
GB917012A GB10940/59A GB1094059A GB917012A GB 917012 A GB917012 A GB 917012A GB 10940/59 A GB10940/59 A GB 10940/59A GB 1094059 A GB1094059 A GB 1094059A GB 917012 A GB917012 A GB 917012A
Authority
GB
United Kingdom
Prior art keywords
cephalin
factor
plasma
reagent
bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10940/59A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB917012A publication Critical patent/GB917012A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A reagent for testing the coagulability of blood during treatment with anticoagulent agents comprises thromboplastin in optimal concentration having a Quick's thromboplastin time of at least 35 seconds with normal human plasma in admixture with cephalin or a cephalin substitute, e.g. lecithin. Bovine plasma from which prothrombin, Stuart-factor, proconvertin and antihemophilia-B-factor have been removed and which contains high concentrations of antihemophilia-A and -C-factors, Hagemanfactor, proaccelarin and proconvertin, and calcium chloride may also be present, the latter in an amount sufficient to give the optimal concentration of Ca\sR\sR ions for coagulation after the addition of test plasmas. The reagent may be freeze-dried to give a stable, solid preparation which may be reconstituted before use. The prothrombin may be prepared by known procedures from animal (e.g. bovine, horse, swine) brain and the cephalin from human brain. The bovine plasma may be obtained by the treatment thereof with barium sulphate followed by dialysis to remove oxalate and the carbonic acid/bicarbonate buffer system and adjustment of the pH to from 6-8.ALSO:A reagent for testing the coagulability of blood during treatment with anticoagulent agents comprises thromboplastin in optional concentration having a Quick's thromboplastin time of at least 35 seconds with normal human plasma in admixture with cephalin or a cephalin substitute e.g. lecithin. Bovine plasma from which prothrombin, Stuart-factor, proconvertin and antihaemophilia-b -factor have been removed and which contains high concentrations of antihaemophilia-A and -C-factors, Hageman-factor, proaccelarin and proconvertin, and calcium chloride may also be present, the latter in amounts sufficient to give the optimal concentration of CA++ ions for coagulation after the addition of test plasma. The reagent may be freeze-dried to give a stable, solid preparation which may be reconstituted before use. The prothrombin may be prepared by known methods from animal (e.g. bovine, horse, swine) brain and the cephalin from human brain. The bovine plasma may be obtained by the treatment thereof with barium sulphate followed by dialysis to remove oxalate and the carbonic acid/bicarbonate buffer system and adjustment of the pH to from 6 to 8.
GB10940/59A 1958-05-16 1959-03-31 Reagent for the control of coagulability of blood Expired GB917012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO12810458 1958-05-16

Publications (1)

Publication Number Publication Date
GB917012A true GB917012A (en) 1963-01-30

Family

ID=19908436

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10940/59A Expired GB917012A (en) 1958-05-16 1959-03-31 Reagent for the control of coagulability of blood

Country Status (7)

Country Link
US (1) US3179567A (en)
CH (1) CH408283A (en)
DE (1) DE1189763B (en)
ES (1) ES249137A1 (en)
FR (1) FR1223856A (en)
GB (1) GB917012A (en)
NL (2) NL123584C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158254A1 (en) * 1984-04-09 1985-10-16 BEHRINGWERKE Aktiengesellschaft Reagent for the determination of the prothrombin-time
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293134A (en) * 1961-09-08 1966-12-20 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
US3486981A (en) * 1965-03-15 1969-12-30 Roy E Speck Substances relating to testing of blood-coagulation
US3228841A (en) * 1965-06-10 1966-01-11 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3880714A (en) * 1973-07-18 1975-04-29 Warner Lambert Co Diagnostic reagent
US3947378A (en) * 1974-12-23 1976-03-30 Warner-Lambert Company Adsorbed plasma
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4038147A (en) * 1976-06-15 1977-07-26 Becton, Dickinson And Company Method for detecting endotoxins
DE2915310A1 (en) * 1979-04-14 1980-10-30 Behringwerke Ag NEW PARTIAL THROMBOPLASTINE AND THEIR USE
DE3150596A1 (en) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR PRODUCING TISSUE HROMBOPLASTIN
DE3407280A1 (en) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin TEST SET FOR DETERMINING THE ACTIVATED PARTIAL THROMBOPLASTIN TIME (PTT) WITH INCREASED HEPARINE SENSITIVITY
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
AU744287B2 (en) * 1990-11-13 2002-02-21 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6203816B1 (en) * 1990-11-13 2001-03-20 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
IS2809B (en) * 2011-03-08 2012-10-15 Haskoli Islands Method for monitoring anticoagulant therapy
CN112481355B (en) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 Liquid prothrombin time determination kit and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687980A (en) * 1948-09-15 1954-08-31 Ernest W Blanchard Thromboplastin product and method for preparing same
US2847350A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Preparation of highly active thromboplastin

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158254A1 (en) * 1984-04-09 1985-10-16 BEHRINGWERKE Aktiengesellschaft Reagent for the determination of the prothrombin-time
US4784944A (en) * 1984-04-09 1988-11-15 Behringwerke Aktiengesellschaft Prothrombin time determining reagent and methods of using and preparing the same
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Also Published As

Publication number Publication date
ES249137A1 (en) 1959-11-16
FR1223856A (en) 1960-06-21
NL123584C (en)
US3179567A (en) 1965-04-20
DE1189763B (en) 1965-03-25
NL238873A (en)
CH408283A (en) 1966-02-28

Similar Documents

Publication Publication Date Title
GB917012A (en) Reagent for the control of coagulability of blood
Ratnoff et al. The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI)
Roughton Recent work on carbon dioxide transport by the blood
Owen et al. Prothrombin conversion factor of dicumarol plasma.
Stefanini Mechanism of blood coagulation in normal and pathologic conditions
JP3055933B2 (en) Improved stable coagulation control
DE3587941D1 (en) DEVICE FOR PROVISIONAL REPERFUSION TREATMENT OF HEART ATTACK SYMPTOMS.
JPS56106594A (en) Stabilizing method of plasminogen
Booth Carbonic anhydrase activity inside corpuscles. Enzyme-substrate accessibility factors
Spaet et al. Inactivation of thromboplastin in human blood
GB834256A (en) Therapeutic bone mixture
DOERR et al. New evidence for intrinsic blood coagulation in chickens
McClaughry et al. Nature of an accelerator of prothrombin activation arising during storage of purified prothrombin.
Gotterer et al. Some factors which influence vesiculase action
McIlwain et al. Induced loss in cerebral tissues of respiratory response to electrical impulses, and its partial restoration by additional substrates
Fujimoto Studies on the antitrypsin of serum
Jürgens Factor VII-inhibitor. A new physiological serum accelerator inactivation principle
Mellanby et al. Calcium and blood coagulation
DE3850728D1 (en) Method for determining the behavior of drugs in living things.
Kawada et al. An appropriate model for congenital hypothyroidism in the rat induced by neonatal treatment with propylthiouracil and surgical thyroidectomy: studies on learning ability and biochemical parameters
GB1003748A (en) Diagnostic compositions for the determination of blood coagulant factor levels
ATE73673T1 (en) AGENT FOR THERAPY OF FACTOR VIII-RESISTANT HAEMOPHILIA A AND METHODS FOR ITS PRODUCTION.
US5021243A (en) Process for the preparation of factor VIII:C-deficient plasma, and a deficient plasma obtained in this way
US3993585A (en) Elevated human lipids control
Smith et al. Lung extract and blood clotting